— Know what they know.
Not Investment Advice

JANX NASDAQ

Janux Therapeutics, Inc.
1W: +0.1% 1M: -6.4% 3M: +10.2% YTD: +5.6% 1Y: -43.3% 3Y: +25.0%
$14.52
+0.11 (+0.76%)
 
Weekly Expected Move ±4.2%
$13 $13 $14 $14 $15
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 38 · $885.5M mcap · 57M float · 1.85% daily turnover · Short 36% of daily vol
Last Earnings 2025-11-06
EPS
$-0.39
▲ Beat +35.0%
Revenue
$10M
▲ Beat +0.0%
Next Earnings 2026-08-06
EPS Estimate
$-0.31
Range: $-0.74 - $0.17
Revenue Estimate
$18M
11 analysts

Estimate vs Actual

Earnings Surprise History

12/18
EPS Beats
12/18
Revenue Beats
67%
EPS Beat Rate
67%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-15 annual 2028-12-31 $-3.41 $-3.37 ▲ 0.04 $18,746,400 $18,746,400
2026-05-15 quarter 2026-12-31 $-0.57 $-0.58 ▼ 0.01 $5,184,538 $4,415,308
2026-05-15 annual 2026-12-31 $-1.89 $-1.88 ▲ 0.01 $29,909,800 $29,492,000
2026-05-15 quarter 2026-09-30 $-0.54 $-0.53 ▲ 0.01 $4,742,071 $4,742,071
2026-05-15 quarter 2026-06-30 $-0.31 $-0.31 $17,937,214 $17,937,214
2026-05-15 annual 2027-12-31 $-2.77 $-2.74 ▲ 0.03 $6,978,571 $6,978,571
2026-05-13 quarter 2027-09-30 $-0.73 $-0.69 ▲ 0.04 $12,442,162 $975,714
2026-05-13 quarter 2028-12-31 $-0.70 $-0.55 ▲ 0.15 $24,205,106 $26,070,106
2026-05-13 annual 2027-12-31 $-3.15 $-2.77 ▲ 0.38 $5,000,000 $6,978,571
2026-05-13 annual 2030-12-31 $-3.10 $-3.10 $198,549,667 $145,426,667
2026-05-13 quarter 2026-06-30 $-0.50 $-0.31 ▲ 0.19 $10,692,857 $17,937,214
2026-05-13 quarter 2026-12-31 $-0.64 $-0.57 ▲ 0.07 $6,230,769 $5,184,538
2026-05-13 quarter 2028-09-30 $-0.70 $-0.55 ▲ 0.15 $17,330,575 $19,195,576
2026-05-13 annual 2028-12-31 $-3.73 $-3.41 ▲ 0.32 $17,913,778 $18,746,400
2026-05-13 annual 2029-12-31 $-3.82 $-3.78 ▲ 0.04 $89,522,222 $75,635,222
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms